amrn stock price guide
AMRN (Amarin Corporation plc) stock price
This article explains what the amrn stock price is, how to read standard market data items for AMRN shares, which corporate and market events move the price, and where investors and traders can monitor AMRN quotes. It is targeted at beginners and intermediate readers who want a reliable reference on the ticker and how to follow real-time and historical price behavior.
Company overview
Amarin Corporation plc is a biopharmaceutical company focused on cardiovascular therapeutics, primarily known for its prescription omega-3 product sold under brand names such as Vascepa and VAZKEPA. The company is incorporated as a public company whose American Depositary Shares (ADS/ADR) trade in U.S. markets under the ticker AMRN. Readers tracking the amrn stock price typically follow clinical trial updates, regulatory developments, product commercialization progress, and quarterly financial results because these items materially influence investor expectations.
Ticker, exchange and share structure
Ticker symbol and trading venue
The ticker for Amarin Corporation plc on U.S. markets is AMRN. The amrn stock price reflects the market quotation for Amarin’s ADS/ADR listed on the NASDAQ and traded in U.S. dollars. When you view the amrn stock price you are seeing quotes for those ADS/ADR units. If an ADR ratio applies (for example, 1 ADS representing X ordinary shares), providers typically note that ratio in the quote summary.
Shares outstanding, float and market capitalization
Key supply-side metrics that relate to the amrn stock price include shares outstanding, public float, and market capitalization. Shares outstanding multiplied by the quoted amrn stock price equals the company’s market capitalization. Public float is the portion of outstanding shares available for public trading and is often used to assess liquidity. Institutional holdings, insider ownership and the float can influence how quickly the amrn stock price moves in response to buying or selling pressure.
Real-time price and market data
When monitoring the amrn stock price, standard live and near-real-time data items include:
- Last trade price and time (the most recent transaction price)
- Bid and ask quotes (current highest bid and lowest ask)
- Price change and percent change versus the previous close
- Pre-market and after-hours quotes (extended-hours trading activity)
- Intraday high and low for the session
- Volume for the current trading session and average volume measures
- 52-week high and 52-week low
- Market capitalization (based on outstanding shares)
Common public data providers for viewing the amrn stock price and related market data include financial news sites and quote services that publish delayed or real-time feeds, as well as brokerage platforms. As of 2026-01-28, according to Investing.com and Morningstar, these pages provide consolidated quote summaries and historical data that many investors use when checking the amrn stock price. For live execution and trading, use a regulated brokerage or exchange platform; on-boarding and data permissions determine whether a feed is real-time or delayed.
Historical price performance
Price history and charts
Historical daily, weekly and monthly price charts are key tools for analyzing the amrn stock price. Charts commonly show candlesticks or line plots of closing prices, overlay moving averages (e.g., 50-day and 200-day) and include technical indicators like the Relative Strength Index (RSI) to assess momentum. Historical key levels such as the 52-week high and 52-week low are frequently cited as reference points for support and resistance.
When reviewing the amrn stock price history, consider volume at price, long-term trend direction, and whether price moves coincide with corporate news (earnings, FDA actions, trial results). Visualizing multiple horizons — intraday, 6-month, 1-year, 3-year — helps separate short-term volatility from longer-term performance.
Total return and multi-period returns
Total return differs from price return by including dividends and other shareholder receipts. Amarin historically has not been a material dividend payer; therefore, total return for the amrn stock price often aligns closely with price return. For multi-period performance, standard metrics include year-to-date (YTD), 1-year, 3-year and 5-year returns. Comparing the amrn stock price returns to sector peers, healthcare indices or a relevant benchmark can provide perspective on relative performance.
Financial metrics and valuation indicators
Fundamental metrics tied to the amrn stock price include revenue, gross profit, operating income, net income, and earnings per share (EPS). Valuation indicators used by analysts when discussing the amrn stock price commonly include:
- Price-to-earnings (P/E) ratio — only meaningful when earnings are positive
- Price-to-sales (P/S) ratio — useful for companies with negative earnings
- Price-to-book (P/B) ratio
- Enterprise value to EBITDA (EV/EBITDA)
- Free cash flow metrics and cash runway for clinical-stage or commercial-stage pharma companies
- Beta — for sensitivity to market moves
For companies with negative net income or volatile earnings, P/S and enterprise-value based metrics are often more informative than P/E. Tracking cash on hand and quarterly cash burn is particularly relevant for interpreting the amrn stock price reaction to funding, licensing or commercialization announcements.
Key corporate events that affect AMRN stock price
Earnings releases and guidance
Quarterly earnings reports, revenue performance for commercial products, and forward guidance are regular catalysts for the amrn stock price. Unexpected beats or misses, and changes to company guidance, often trigger immediate intraday moves as traders reprice expectations.
Regulatory news and clinical data
For Amarin, regulatory outcomes and clinical-trial data are among the most significant drivers of the amrn stock price. FDA actions, label expansions, or published trial results (for example, analyses related to the REDUCE-IT program and subsequent evidence) can materially change investor sentiment. Positive clinical readouts or favorable regulatory decisions typically lift the amrn stock price, while negative data or regulatory setbacks can produce sharp declines.
Corporate actions (stock splits, ADR ratio changes, delisting/compliance events)
Corporate events such as stock splits, changes to the ADR ratio, Nasdaq compliance notices, or restructurings can affect liquidity, share count and market perception — all of which can influence the amrn stock price. Notices about listing compliance or potential delisting are especially impactful because they affect tradability for retail and institutional holders.
Market trading characteristics
Liquidity and average volume
Liquidity for AMRN is measured by daily trading volume, bid-ask spread and order-book depth. Higher average daily volume implies easier execution and tighter spreads; low-volume periods can widen spreads and increase execution cost for retail traders. When tracking the amrn stock price, observe both absolute volume and average volume across recent periods to assess liquidity conditions.
Volatility and beta
Volatility measures — intraday range, historical volatility, and beta versus the broader market — indicate how sensitive the amrn stock price has been to market moves or company-specific news. Biotech and small-cap pharmaceutical stocks often exhibit higher volatility than large-cap, diversified companies because a single trial result or regulatory outcome can dramatically alter the company’s outlook.
Analyst coverage, price targets and sentiment
Sell-side analyst ratings, consensus price targets and independent research summaries contribute to the narrative around the amrn stock price. Analysts publish model-based valuations and forecasts that market participants use to form expectations. Aggregators such as Morningstar and institutional reports compile consensus opinions; changes in consensus price targets or net recommendation counts may influence short-term flows into or out of the stock.
Major factors and risks influencing AMRN stock price
Key risk categories that typically drive amrn stock price volatility include:
- Regulatory risk: FDA decisions, label changes, or safety warnings
- Clinical risk: Trial outcomes, data releases, or adverse events
- Commercialization and reimbursement: Sales performance, payer coverage, and pricing pressure
- Litigation and intellectual property: Patent disputes or settlements
- Financing risk: Need for capital raises and dilution risk
- Competition: New therapies or generics that affect market share
- Macro and liquidity risk: Market-wide selloffs or changes in risk appetite
All these factors can interact, and a combination of events often explains large moves in the amrn stock price.
How to access AMRN price data
For investors and traders seeking the amrn stock price, practical sources include brokerage platforms, financial news sites, and official corporate disclosures. Key considerations when choosing a source:
- Real-time vs delayed data: Many free quote pages provide delayed feeds (e.g., 15–20 minutes), while brokerages with market data subscriptions may offer real-time quotes.
- Extended-hours pricing: Pre-market and after-hours trades appear on specialized quote lines; check whether the provider shows extended-hours last trade.
- Data depth: For active traders, level-2 order-book data provides insight into liquidity beyond the top-of-book bid/ask.
For execution and trading access, professional and retail users can open an account with a regulated brokerage or trade execution platform. If you prefer a single platform that provides integrated market data and trading, consider using Bitget for on-platform market monitoring and order execution. Bitget supports equity trading access and provides configurable quote displays and alerts for the amrn stock price.
Sample timeline of notable price-moving events
Below are representative events that historically affected the amrn stock price. Dates are included for context; consult primary sources for precise documentation.
- 2018 — REDUCE-IT trial results published: A major trial examining cardiovascular outcomes associated with prescription icosapent ethyl produced high-profile results that materially affected sentiment around Amarin and the amrn stock price.
- 2019 — FDA label and regulatory developments: Regulatory actions and label-related decisions in late 2010s and early 2020s influenced market expectations and the amrn stock price.
- 2020–2021 — Commercialization updates: Sales trends, payer decisions and quarterly results during commercialization phases drove short-term moves in the amrn stock price.
- 2022–2024 — Ongoing clinical/regulatory news and corporate filings: Periodic 8-K filings, SEC disclosures and clinical updates continued to create volatility in the amrn stock price.
As of 2026-01-28, according to Investing.com and Morningstar, financial-news coverage and quote pages continue to highlight similar classes of events when summarizing major price moves for the amrn stock price.
Investor relations and disclosures
Authoritative corporate facts for Amarin — including SEC filings such as Form 10-K, Form 10-Q and Form 8-K — are the primary sources for company-reported financials and material corporate events. For any material item that could affect the amrn stock price (financial statements, material agreements, or corporate actions), consult the company’s investor relations releases and official SEC filings. Public filings contain the factual disclosures needed to assess the company’s position and are the basis for professional analysis.
Data sources, methodology and disclaimers
Common public data providers used to compile quotes and fundamentals for the amrn stock price include financial news and market-data services that publish price, volume and fundamental datasets. Examples of providers frequently cited by investors include major financial data platforms and market quote aggregators. Market prices change rapidly; the content in this guide is informational and does not constitute investment advice. Always verify live quotes and consult licensed professionals before making trading or investment decisions.
See also
- Vascepa / VAZKEPA product information and clinical evidence
- REDUCE-IT trial summaries and published analyses
- ADR / ADS structure and how U.S. ADRs trade
- Comparable healthcare and biotech tickers for relative performance analysis
Appendix A: Historical price table (selected dates)
The table below provides example checkpoints that readers commonly review when studying the amrn stock price. For exact historical closing prices on the dates listed, check an authoritative historical-quote service or the company’s filings.
- IPO / ADR listing date — reference price at listing (see primary filing)
- 52-week high — key high watermark over the last 12 months
- 52-week low — key low watermark over the last 12 months
- Recent quarter-end closes — closing prices on the most recent fiscal quarter ends
Appendix B: Glossary of market terms used
- ADR / ADS: Depositary receipt instruments that represent a company’s shares for U.S. investors.
- Market capitalization: Shares outstanding multiplied by the current market price.
- Float: The portion of shares available to public investors, excluding locked-up or insider-held shares.
- Bid / Ask: The highest buy price and lowest sell price quoted in the market.
- Volume: Number of shares traded during a period.
- After-hours trading: Trades occurring outside standard market hours that may update the amrn stock price in extended sessions.
Reporting snapshot and data note
As of 2026-01-28, according to Investing.com and Morningstar, the public quote pages and data summaries for AMRN show the typical quote fields described above (last trade, change %, volume, market cap and historical charts). For precise numeric values — including the live amrn stock price, market capitalization and session volume — consult your brokerage’s real-time feed or the market-data page on a trusted provider. This guide is informational and not a source of live market quotes.
How to monitor the amrn stock price on Bitget
To monitor the amrn stock price and related market data on Bitget:
- Create and verify an account on Bitget following the platform’s onboarding process.
- Use the watchlist feature to add AMRN and configure price alerts for specific price levels, percentage moves or volume spikes.
- Enable extended-hours quotes if your Bitget interface supports after-hours pricing for U.S. equities.
- Review historical charts and overlay technical indicators (moving averages, RSI) directly in the Bitget chart interface for integrated technical views.
Bitget provides an integrated environment to view quotes, place orders and store credentials for trading. If you are new to trading, consider using demo or paper-trading functionality (if available) to practice placing orders before committing funds.
Final notes and reader next steps
Tracking the amrn stock price requires attention to both company fundamentals and event-driven news. Regularly review Amarin’s investor relations releases and SEC filings for primary source information and use a reliable market-data provider or a regulated brokerage like Bitget to obtain real-time quotes. If you want to follow price movements closely, set alerts for earnings releases, major clinical updates and regulatory filings — these items historically produce the largest volatility for AMRN.
Further explore AMRN trading tools on Bitget to set alerts, save watchlists and configure charting templates to streamline monitoring the amrn stock price. This article is for informational purposes only and does not provide investment advice.
Sources and reporting dates: As of 2026-01-28, according to Investing.com and Morningstar reporting and Amarin investor relations disclosures.
